Compound ID | 2965
Class: Membrane-active agent
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against oral infections caused by Porphyromonas gingivalis and Streptococcus mutans; likely disrupts integrity of cytoplasmic membrane |
| Description: | Synthetic compound; a repurposed FDA-approved drug for breast cancer treatment |
| Year first mentioned: | 2017 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3005573 |
| Citation: | https://journals.asm.org/doi/10.1128/aac.01846-16 |